At Bioptigen, Images Matter.
We are committed to providing the ophthalmic community with the advanced SDOCT imaging technologies required to advance their research and clinical objectives. Through a continuous collaboration with thought leaders in the dynamic and evolving ophthalmic and optometric medical communities, we seek to advance life-improving techniques through a deeper understanding of disease progression. Our goal in this endeavor is to provide the best SDOCT images over the broadest range of subjects. View our image gallery.
Bioptigen Envisu Spectral Domain Ophthalmic Imaging Systems
Bioptigen’s proprietary Envisu™ Spectral Domain Ophthalmic Imaging Systems (SDOIS) use low powered near infrared light to generate depth-resolved images of ocular tissue structures, non-invasively and in real-time. Based on proprietary implementations of spectral domain optical coherence tomography, Envisu systems expose details of healthy, diseased, and treated tissues at resolutions 100 times finer than ultrasound, without contact and without discomfort.
Bioptigen Envisu imaging systems are deployed in each of the top 10 US ophthalmic research institutions, in similar institutions worldwide, and in many top ophthalmic equipment and pharmaceutical companies in support of pre-clinical research and development. View our product information.
Available for clinical use in the US and other countries.
Bioptigen is committed to serving the ophthalmology community. Bioptigen recently expanded their clinical indications to include even the youngest pediatrics through receipt of the first FDA 510(k) clearance to market OCT imaging technology for premature infants. Our Envisu SDOIS handheld imaging system is now available in the US, Canada, the European Union and Australia.
Bioptigen is an ISO 13485-certified medical device company committed to bringing the best in high resolution imaging to our customers. We invite you to learn more about SDOCT imaging technology, see sample image galleries, compare the features of Envisu systems and meet the people who make them possible.